13D Filing: Park West Asset Management and PLX Pharma Inc. (PLXP)

*Beneficial ownership percentage is based upon 8,721,691 shares of Common Stock issued and outstanding as of November 3, 2017, based
on information reported by the Issuer in its quarterly report on Form 10-Q, filed with the Securities and Exchange Commission on
November 9, 2017. PWAM is the investment manager to the PW Funds, and Mr. Park is the sole member and manager of PWAM.  As
of the Event Date, PWIMF held 953,465 shares of Common Stock and, subject to the limitation described below, warrants to purchase
up to 902,528 shares of Common Stock and PWPI held 122,258 shares of Common Stock and, subject to the limitation described below,
warrants to purchase up to 115,653 shares of Common Stock.  The warrants are not exercisable until December 15, 2017,
expire on June 14, 2027, and contain a provision prohibiting exercise to the extent that the holder, together with its affiliates,
would beneficially own in excess of 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to
such exercise (subject to decrease upon prior written notice to the Issuer). As a result of the foregoing, for purposes of Reg.
Section 240.13d-3, Mr. Park may be deemed to beneficially own the 1,075,723 shares of Common Stock held in the aggregate by the
PW Funds, and no shares of Common Stock underlying the warrants held in the aggregate by the PW Funds, for an aggregate beneficial
ownership percentage of approximately 12.3% of the shares of Common Stock deemed issued and outstanding as of the Event Date.